Joint (NASDAQ:JYNT – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Thursday.
Joint Trading Down 2.3 %
Shares of NASDAQ:JYNT opened at $11.61 on Thursday. The firm has a fifty day moving average of $11.26 and a 200 day moving average of $12.96. Joint has a 52-week low of $7.31 and a 52-week high of $17.82.
Joint (NASDAQ:JYNT – Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The firm had revenue of $30.26 million during the quarter, compared to analysts’ expectations of $29.65 million. Joint had a positive return on equity of 2.17% and a negative net margin of 12.00%. As a group, equities analysts anticipate that Joint will post 0.13 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Joint
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
See Also
- Five stocks we like better than Joint
- Financial Services Stocks Investing
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- About the Markup Calculator
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.